The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...
The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...
Medicare Part B premiums are set to rise 11.6% by 2026, putting added pressure on retirees’ budgets. Learn what’s driving the ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
Original Medicare will launch a multi-state pilot program requiring prior authorization for certain devices, procedures, and ...
Two widely available diabetes medications appear to help people in early brain decline. Empagliflozin and nasal insulin spray ...